Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bolla

Showing results (211-220 of 237) with videos related to

Pageof 24
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1992
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyJ C Horiot, R Le Fur, T N'Guyen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2014
Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?G Créhange, M Roach, E Martin, et al.
Neurology|May 6, 2009
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineursC Di Lorenzo, F Pierelli, G Coppola, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]N Mottet, J Bellmunt, M Bolla, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative GroupG M Kiebert, D Curran, N K Aaronson, et al.
European Urology|August 6, 2002
Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863A Zurlo, L Collette, G van Tienhoven, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]A Heidenreich, J Bellmunt, M Bolla, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 8, 2006
[Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association]P Fourneret, X Artignan, J De Cornulier, et al.
The New England Journal of Medicine|July 31, 1997
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelinM Bolla, D Gonzalez, P Warde, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2000
Effect of endogenous and exogenous prostaglandin E(2) on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cellsA Bonazzi, M Bolla, C Buccellati, et al.
Pageof 24

Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1992
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyJ C Horiot, R Le Fur, T N'Guyen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2014
Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?G Créhange, M Roach, E Martin, et al.
Neurology|May 6, 2009
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineursC Di Lorenzo, F Pierelli, G Coppola, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]N Mottet, J Bellmunt, M Bolla, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative GroupG M Kiebert, D Curran, N K Aaronson, et al.
European Urology|August 6, 2002
Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863A Zurlo, L Collette, G van Tienhoven, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]A Heidenreich, J Bellmunt, M Bolla, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 8, 2006
[Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association]P Fourneret, X Artignan, J De Cornulier, et al.
The New England Journal of Medicine|July 31, 1997
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelinM Bolla, D Gonzalez, P Warde, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2000
Effect of endogenous and exogenous prostaglandin E(2) on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cellsA Bonazzi, M Bolla, C Buccellati, et al.
Pageof 24